Life Sciences IP Review

EPO reports record patent filings, but pharma and biotech lag

March 2026 After an overwhelmingly positive Supreme Court ruling for companies working in AI, Rachel Free of CMS outlines the ...
Life Sciences IP Review

UK court deals blow to Spanish pharma’s SPC bid for contraceptive

March 2026 After an overwhelmingly positive Supreme Court ruling for companies working in AI, Rachel Free of CMS outlines the ...
Life Sciences IP Review

Part II: The race to replace semaglutide heats up

The race to replace semaglutide heats up ...
Life Sciences IP Review

Part I: Ozempic goes generic as Novo’s key patent expires

As the patent protecting semaglutide—the drug that made Novo Nordisk one of Europe's most valuable companies—expires in ten ...
Life Sciences IP Review

Masimo convinces judge that Apple took secrets—but it’s not enough

Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry ...
Life Sciences IP Review

US firm boosts patent bench with Desmarais hire

12 March 2026 With life sciences companies increasingly reliant on complex IP and licensing deals, the firm’s new hire is set ...